BioSpace News Archive

Cardiawave SA, a deeptech medical device company that has developed VALVOSOFT® a revolutionary non-invasive medical device to treat aortic stenosis, the most prevalent heart valve disease in adults, today announced the success of its First-In-Human I (FIH I) safety and feasibility clinical trial.

Agile Therapeutics, Inc. today announced that it has closed its previously announced registered direct offering with a single healthcare-focused institutional investor to sell 2,425 shares of Series A convertible preferred stock.

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today provided a business update and released financial results for the year ended December 31, 2021.

Biogen Inc. (Nasdaq: BIIB) and Eisai Co., Ltd. (Tokyo, Japan) announced today that the companies have amended their existing collaboration agreement on aducanumab, which is commercialized in the United States as ADUHELM® (aducanumab-avwa).

Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) today announced topline results from the ongoing Phase 3 MOONLIGHT 1™ clinical trial investigating the efficacy and safety of fezolinetant, an investigational oral, nonhormonal compound being studied for the treatment of moderate to severe vasomotor symptoms associated with menopause (VMS), in women in Asia.

Everest Medicines announced that it will report financial results for the full year ended December 31, 2021 and provide a business update on March 29, 2022.

Albany NY, United States: The global cardiac surgery instruments market is driven primarily by the growing prevalence of cardiac disorders across the world.

Albany NY, United States: The global brachytherapy devices market has numerous players operating both at the global and local level.

DUBAI, United Arab Emirates, Growing at a CAGR of 5%, the global Companion Animal Drugs Market is anticipated to increase from a valuation of US$ 36.94 Billion in 2022 to US$ 47.23 Billion by the end of 2027.

Albany NY, United States: The world market for surgical tables is dominated by already established international market vendors whilst local market participants jostle to make a positive impact on the said industry.